DIY peptide injections are risky, and people may make serious mistakes when administering them
On top of the risks of injecting untested and potentially contaminated products, user error may make this runaway wellness fad even more dangerous.
Gray-market peptides, which promise to boost various aspects of health such as weight loss, muscle-building, longevity, and sexual health, are a growing concern due to their high-risk nature. These unregulated products, not subject to the scrutiny of the U.S. Food and Drug Administration (FDA) or other health authorities, may contain harmful contaminants like bacteria, fungi, chemicals, or heavy metals.
Their purity might be lower than indicated, and the doses provided could be inaccurate, leading to potential dangers for consumers. A recent study conducted by a pharmacist and clinical pharmacologist reveals that users often make serious mistakes when administering these peptides, resulting in serious harm.
Access to these peptides is largely unguided, as consumers must figure out the proper techniques on their own. In the study, participants were given a vial of a semaglutide GLP-1 peptide product and tasked with dissolving the powder, drawing it up into a syringe, and injecting it into a mannequin's arm or belly. Despite using the internet or artificial intelligence for research, the majority of both younger and older participants made significant errors in the injection process.
These mistakes ranged from using expired vials to injecting into the wrong location, such as muscle rather than the arm or belly fat.
Such errors could lead to severe consequences, including infection, bleeding, overdosing or underdosing, and needle sticks. Interestingly, participants in both age groups initially reported feeling somewhat confident in their ability to administer the peptides correctly. However, this confidence waned after experiencing the challenges of the injection process.
This overconfidence in users' abilities may further increase the risks associated with these unregulated substances. To address this issue, some companies are developing specialized pens for injecting prescription peptides, aiming to simplify the process for untrained individuals. The FDA is also exploring the option of allowing compounding pharmacies to manufacture and sell peptides, believing that these pharmacies' strict protocols for safe sourcing, testing, and sterile environments could lead to safer peptide use.
Written by urgent.news from The Conversation's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
